Erlotinib: optimizing therapy with predictors of response?
作者信息
Goodin Susan
机构信息
Pharmaceutical Sciences, The Cancer Institute of New Jersey and Division of Medical Oncology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, NJ 08903-2681, USA.
出版信息
Clin Cancer Res. 2006 May 15;12(10):2961-3. doi: 10.1158/1078-0432.CCR-06-0426.
Abstract
摘要
Zotero 插件